Table 3.
Results of the Unadjusted Analysis for the Relationship Between Body Mass Index and Survival among 233 Patients with Stage D Heart Failure on Long-term Milrinone Infusion
| Variable | Hazard Ratio (95% CI) | P Value |
|---|---|---|
| BMI group (ref BMI < 30 kg/m2) | 0.30 | |
| BMI 30 to 35 kg/m2 | 0.68 (0.37-1.27) | |
| BMI > 35 kg/m2 | 1.21 (0.72-2.02) | |
| Male | 0.80 (0.52-1.21) | 0.29 |
| Age group, years (ref age < 55) | < 0.001 | |
| 55-69 | 1.76 (1.00-3.09) | |
| 70+ | 3.11 (1.73-5.60) | |
| Non-White race | 0.75 (0.49-1.14) | 0.18 |
| LVAD | 0.43 (0.26-0.72) | 0.001 |
| Heart Transplant | 0.20 (0.03-1.49) | 0.12 |
| DM | 1.10 (0.72-1.67) | 0.67 |
| CKD | 0.86 (0.31-2.34) | 0.76 |
| Atrial Fibrillation | 1.47 (0.96-2.24) | 0.07 |
| COPD | 0.54 (0.25-1.18) | 0.12 |
| History of CVA/TIA | 0.60 (0.22-1.64) | 0.32 |
BMI, body mass index; LVAD, left ventricular assist device; DM, diabetes melitis; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebral vascular accident; TIA, transient ischemic attack.